Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3350 | 1928 | 33.1 | 77% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2161 | 4516 | ANGIOMYOLIPOMA//TUBEROUS SCLEROSIS//TUBEROUS SCLEROSIS COMPLEX |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | TUBEROUS SCLEROSIS | Author keyword | 321 | 50% | 24% | 463 |
2 | TUBEROUS SCLEROSIS COMPLEX | Author keyword | 241 | 58% | 14% | 278 |
3 | SUBEPENDYMAL GIANT CELL ASTROCYTOMA | Author keyword | 190 | 90% | 4% | 82 |
4 | HAMARTIN | Author keyword | 109 | 83% | 3% | 62 |
5 | TUBERIN | Author keyword | 102 | 69% | 5% | 88 |
6 | TSC2 | Author keyword | 73 | 52% | 5% | 98 |
7 | TSC1 | Author keyword | 73 | 67% | 3% | 66 |
8 | SEGA | Author keyword | 29 | 75% | 1% | 21 |
9 | SUBEPENDYMAL NODULE | Author keyword | 27 | 92% | 1% | 11 |
10 | TUBEROUS SCLEROSIS CLIN | Address | 21 | 90% | 0% | 9 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TUBEROUS SCLEROSIS | 321 | 50% | 24% | 463 | Search TUBEROUS+SCLEROSIS | Search TUBEROUS+SCLEROSIS |
2 | TUBEROUS SCLEROSIS COMPLEX | 241 | 58% | 14% | 278 | Search TUBEROUS+SCLEROSIS+COMPLEX | Search TUBEROUS+SCLEROSIS+COMPLEX |
3 | SUBEPENDYMAL GIANT CELL ASTROCYTOMA | 190 | 90% | 4% | 82 | Search SUBEPENDYMAL+GIANT+CELL+ASTROCYTOMA | Search SUBEPENDYMAL+GIANT+CELL+ASTROCYTOMA |
4 | HAMARTIN | 109 | 83% | 3% | 62 | Search HAMARTIN | Search HAMARTIN |
5 | TUBERIN | 102 | 69% | 5% | 88 | Search TUBERIN | Search TUBERIN |
6 | TSC2 | 73 | 52% | 5% | 98 | Search TSC2 | Search TSC2 |
7 | TSC1 | 73 | 67% | 3% | 66 | Search TSC1 | Search TSC1 |
8 | SEGA | 29 | 75% | 1% | 21 | Search SEGA | Search SEGA |
9 | SUBEPENDYMAL NODULE | 27 | 92% | 1% | 11 | Search SUBEPENDYMAL+NODULE | Search SUBEPENDYMAL+NODULE |
10 | CORTICAL TUBER | 19 | 80% | 1% | 12 | Search CORTICAL+TUBER | Search CORTICAL+TUBER |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HAMARTIN | 143 | 79% | 5% | 91 |
2 | TSC1 | 124 | 69% | 5% | 106 |
3 | EKER RAT MODEL | 121 | 75% | 5% | 87 |
4 | TSC2 GENE | 81 | 67% | 4% | 74 |
5 | CORTICAL TUBERS | 79 | 88% | 2% | 37 |
6 | HAMARTIN COMPLEX | 62 | 92% | 1% | 24 |
7 | DOMINANTLY INHERITED CANCER | 58 | 68% | 3% | 52 |
8 | CLINICORADIOLOGICAL EVALUATION | 41 | 100% | 1% | 15 |
9 | TUBEROUS SCLEROSIS COMPLEX | 40 | 17% | 11% | 218 |
10 | TSC1 GENE | 40 | 76% | 1% | 28 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The tuberous sclerosis complex | 2006 | 580 | 94 | 73% |
Mechanistic Target of Rapamycin (mTOR) in Tuberous Sclerosis Complex-Associated Epilepsy | 2015 | 3 | 63 | 89% |
Analysis of current data on the use of topical rapamycin in the treatment of facial angiofibromas in Tuberous Sclerosis Complex | 2015 | 2 | 12 | 83% |
Disentangling the heterogeneity of autism spectrum disorder through genetic findings | 2014 | 36 | 74 | 32% |
Tuberous sclerosis | 2008 | 221 | 136 | 73% |
Advances in the treatment of tuberous sclerosis complex | 2015 | 1 | 39 | 97% |
Tuberous sclerosis complex and epilepsy: Recent developments and future challenges | 2007 | 108 | 111 | 83% |
Tuberous sclerosis: from tubers to mTOR | 2003 | 206 | 53 | 70% |
Neurological and neuropsychiatric aspects of tuberous sclerosis complex | 2015 | 1 | 88 | 80% |
Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature | 2009 | 56 | 18 | 89% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TUBEROUS SCLEROSIS CLIN | 21 | 90% | 0.5% | 9 |
2 | PENN EPILEPSY | 13 | 41% | 1.3% | 25 |
3 | CAROL JAMES HERSCOT TUBEROUS SCLEROSIS COMP | 6 | 71% | 0.3% | 5 |
4 | EXPERTISE NEURODEV DISORDERS | 6 | 71% | 0.3% | 5 |
5 | BATH UNIT PAEDIAT | 4 | 47% | 0.4% | 7 |
6 | NEURODEV SERV NDS | 4 | 67% | 0.2% | 4 |
7 | EXPT MED MED ONCOL | 3 | 100% | 0.2% | 3 |
8 | TSC CLIN | 3 | 100% | 0.2% | 3 |
9 | DEV PSYCHIAT SECT | 3 | 15% | 1.0% | 19 |
10 | FM KIRBY NEUROBIOL NEUROL | 2 | 29% | 0.4% | 7 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000264102 | LYMPHANGIOLEIOMYOMATOSIS//MULTIFOCAL MICRONODULAR PNEUMOCYTE HYPERPLASIA//PULMONARY LYMPHANGIOLEIOMYOMATOSIS |
2 | 0.0000153991 | CARDIAC RHABDOMYOMA//RHABDOMYOMA//INTRAPERICARDIAL TERATOMA |
3 | 0.0000135176 | ANGIOMYOLIPOMA//PECOMA//EPITHELIOID ANGIOMYOLIPOMA |
4 | 0.0000090780 | MTOR//RAPAMYCIN//CCI 779 |
5 | 0.0000071316 | BIRT HOGG DUBE SYNDROME//FOLLICULIN//FIBROFOLLICULOMA |
6 | 0.0000068522 | WEISMANN NETTER STUHL SYNDROME//GLOMERULOCYSTIC KIDNEY//GLOMERULOCYSTIC KIDNEY DISEASE |
7 | 0.0000063124 | LISSENCEPHALY//CORTICAL DYSPLASIA//SCHIZENCEPHALY |
8 | 0.0000059794 | WEST SYNDROME//INFANTILE SPASMS//HYPSARRHYTHMIA |
9 | 0.0000055409 | STURGE WEBER SYNDROME//CHOROIDAL HEMANGIOMA//CIRCUMSCRIBED CHOROIDAL HEMANGIOMA |
10 | 0.0000045083 | COATS DISEASE//IDIOPATHIC MACULAR TELANGIECTASIA//MACULAR TELANGIECTASIA |